sanguinarine has been researched along with B16 Melanoma in 3 studies
benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sanguinarine has a history of use in both folk medicine and early dermatology for the treatment of cutaneous neoplasms." | 1.42 | Characterization and assessment of nanoencapsulated sanguinarine chloride as a potential treatment for melanoma. ( Adler, BL; Doerner, J; Friedman, AJ; Gravekamp, C; Krauz, A; Landriscina, A; Musaev, T; Navati, M; Nosanchuk, J; Rosen, J, 2015) |
| "Sanguinarine (SANG) is an alkaloid recognized to have anti-proliferative activity against various human tumour cell lines." | 1.35 | Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects. ( Branco, AF; Holy, J; Matos, JA; Moreno, AJ; Oliveira, PJ; Parke, D; Pereira, GC; Pereira, SL; Perkins, EL; Sardão, VA; Serafim, TL, 2008) |
| "Oral treatment with sanguinarine reduced the tumor burden in a transplantable murine tumor grown in a syngeneic host (B16 melanoma 4A5 in C57BL/6 mice), and in a human tumor xenograft grown in immunodeficient mice (A375 human melanoma in athymic nude mice)." | 1.35 | Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. ( De Stefano, I; Ferlini, C; Gallo, D; Mosca, M; Prisco, MG; Raspaglio, G; Scambia, G; Travaglia, D; Zannoni, GF, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosen, J | 1 |
| Landriscina, A | 1 |
| Adler, BL | 1 |
| Krauz, A | 1 |
| Doerner, J | 1 |
| Navati, M | 1 |
| Musaev, T | 1 |
| Gravekamp, C | 1 |
| Nosanchuk, J | 1 |
| Friedman, AJ | 1 |
| Serafim, TL | 1 |
| Matos, JA | 1 |
| Sardão, VA | 1 |
| Pereira, GC | 1 |
| Branco, AF | 1 |
| Pereira, SL | 1 |
| Parke, D | 1 |
| Perkins, EL | 1 |
| Moreno, AJ | 1 |
| Holy, J | 1 |
| Oliveira, PJ | 1 |
| De Stefano, I | 1 |
| Raspaglio, G | 1 |
| Zannoni, GF | 1 |
| Travaglia, D | 1 |
| Prisco, MG | 1 |
| Mosca, M | 1 |
| Ferlini, C | 1 |
| Scambia, G | 1 |
| Gallo, D | 1 |
3 other studies available for sanguinarine and B16 Melanoma
| Article | Year |
|---|---|
Characterization and assessment of nanoencapsulated sanguinarine chloride as a potential treatment for melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Delayed-Action Preparations; Drug D | 2015 |
Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects.
Topics: Animals; Benzophenanthridines; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Cell Proliferation | 2008 |
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzophenanthridines; Cell Line, Tumor; Cel | 2009 |